Preliminary data from a pharmacovigilance study suggested preferential involvement of the CTLA‐4 pathway in the development of ICI‐induced GCA, as patients with temporal arteritis were more likely to have received anti–CTLA‐4 treatment.40 Here, CTLA4 is linked to temporal arteritis.